Aboubacar Oumar, Pharm.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Malaria, Cerebral | 6 | 2020 | 134 | 0.680 |
Why?
|
| Benzoxazines | 1 | 2018 | 309 | 0.550 |
Why?
|
| Breast Feeding | 1 | 2018 | 1357 | 0.340 |
Why?
|
| Mothers | 1 | 2018 | 2181 | 0.290 |
Why?
|
| Anti-HIV Agents | 3 | 2018 | 4490 | 0.270 |
Why?
|
| Mali | 5 | 2018 | 50 | 0.250 |
Why?
|
| Ritonavir | 1 | 2022 | 328 | 0.180 |
Why?
|
| HIV Infections | 4 | 2022 | 17128 | 0.160 |
Why?
|
| Malaria, Falciparum | 3 | 2017 | 1076 | 0.150 |
Why?
|
| Alkynes | 1 | 2018 | 313 | 0.150 |
Why?
|
| Cyclopropanes | 1 | 2018 | 430 | 0.140 |
Why?
|
| Receptors, Interleukin-17 | 1 | 2015 | 81 | 0.130 |
Why?
|
| Tissue Distribution | 1 | 2018 | 2262 | 0.120 |
Why?
|
| Safety | 1 | 2018 | 1149 | 0.110 |
Why?
|
| Interleukins | 1 | 2017 | 780 | 0.100 |
Why?
|
| Erythrocytes | 1 | 2020 | 2416 | 0.090 |
Why?
|
| Polymorphism, Single Nucleotide | 3 | 2017 | 15750 | 0.090 |
Why?
|
| Pyrrolidinones | 1 | 2010 | 116 | 0.090 |
Why?
|
| HIV-2 | 1 | 2010 | 156 | 0.090 |
Why?
|
| HIV Integrase | 1 | 2010 | 121 | 0.080 |
Why?
|
| Interleukin-17 | 1 | 2015 | 908 | 0.080 |
Why?
|
| Poliovirus | 1 | 2009 | 106 | 0.080 |
Why?
|
| Drug Resistance, Viral | 2 | 2012 | 857 | 0.080 |
Why?
|
| Minisatellite Repeats | 1 | 2009 | 164 | 0.080 |
Why?
|
| Poliomyelitis | 1 | 2009 | 95 | 0.080 |
Why?
|
| Neurodegenerative Diseases | 1 | 2017 | 1080 | 0.080 |
Why?
|
| Interleukin-4 | 1 | 2009 | 1132 | 0.060 |
Why?
|
| Alleles | 1 | 2017 | 6897 | 0.060 |
Why?
|
| Infant | 6 | 2018 | 35941 | 0.060 |
Why?
|
| Cholera | 1 | 2009 | 774 | 0.050 |
Why?
|
| Linkage Disequilibrium | 2 | 2017 | 1995 | 0.050 |
Why?
|
| Inflammation | 1 | 2020 | 10747 | 0.040 |
Why?
|
| Polymorphism, Genetic | 1 | 2010 | 4286 | 0.040 |
Why?
|
| Disease Outbreaks | 1 | 2009 | 1758 | 0.040 |
Why?
|
| Chemokine CXCL10 | 1 | 2020 | 316 | 0.040 |
Why?
|
| Chromatography, Liquid | 1 | 2022 | 985 | 0.040 |
Why?
|
| Interleukin-18 | 1 | 2020 | 251 | 0.040 |
Why?
|
| Anemia | 1 | 2008 | 1509 | 0.040 |
Why?
|
| Milk, Human | 1 | 2022 | 484 | 0.040 |
Why?
|
| Genetic Predisposition to Disease | 2 | 2017 | 17750 | 0.040 |
Why?
|
| Tandem Mass Spectrometry | 1 | 2022 | 1183 | 0.030 |
Why?
|
| Ubiquitins | 1 | 2017 | 370 | 0.030 |
Why?
|
| Genotype | 3 | 2017 | 12940 | 0.030 |
Why?
|
| Adolescent | 4 | 2018 | 87560 | 0.030 |
Why?
|
| HSP70 Heat-Shock Proteins | 1 | 2017 | 398 | 0.030 |
Why?
|
| Child, Preschool | 6 | 2017 | 41935 | 0.030 |
Why?
|
| HIV-1 | 1 | 2012 | 6848 | 0.030 |
Why?
|
| Nigeria | 1 | 2017 | 762 | 0.030 |
Why?
|
| Young Adult | 2 | 2018 | 58483 | 0.030 |
Why?
|
| Tubulin | 1 | 2017 | 692 | 0.030 |
Why?
|
| Africa | 1 | 2015 | 706 | 0.030 |
Why?
|
| Brain | 1 | 2020 | 26863 | 0.030 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2020 | 4573 | 0.030 |
Why?
|
| Female | 9 | 2022 | 390240 | 0.030 |
Why?
|
| Anti-Retroviral Agents | 1 | 2022 | 1780 | 0.030 |
Why?
|
| Ubiquitin | 1 | 2017 | 838 | 0.030 |
Why?
|
| Sequence Analysis | 1 | 2012 | 240 | 0.020 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2020 | 3774 | 0.020 |
Why?
|
| alpha-Synuclein | 1 | 2017 | 744 | 0.020 |
Why?
|
| Proteasome Endopeptidase Complex | 1 | 2017 | 1314 | 0.020 |
Why?
|
| Child | 6 | 2017 | 79623 | 0.020 |
Why?
|
| Genetics, Population | 1 | 2015 | 924 | 0.020 |
Why?
|
| Leukocytes, Mononuclear | 1 | 2017 | 1827 | 0.020 |
Why?
|
| Protein Kinases | 1 | 2017 | 1612 | 0.020 |
Why?
|
| Humans | 12 | 2022 | 759255 | 0.020 |
Why?
|
| Down-Regulation | 1 | 2017 | 2920 | 0.020 |
Why?
|
| Up-Regulation | 1 | 2017 | 4132 | 0.020 |
Why?
|
| Computational Biology | 1 | 2020 | 3505 | 0.020 |
Why?
|
| Ubiquitin-Protein Ligases | 1 | 2017 | 1889 | 0.020 |
Why?
|
| Plasmodium falciparum | 1 | 2017 | 1741 | 0.020 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2017 | 2896 | 0.020 |
Why?
|
| Endemic Diseases | 1 | 2008 | 190 | 0.020 |
Why?
|
| CD4 Lymphocyte Count | 1 | 2012 | 2569 | 0.020 |
Why?
|
| Genetic Association Studies | 1 | 2015 | 2712 | 0.020 |
Why?
|
| Adult | 2 | 2018 | 219390 | 0.020 |
Why?
|
| Odds Ratio | 1 | 2017 | 9711 | 0.010 |
Why?
|
| Phylogeny | 1 | 2010 | 2765 | 0.010 |
Why?
|
| Male | 7 | 2017 | 358719 | 0.010 |
Why?
|
| Nuclear Proteins | 1 | 2017 | 5793 | 0.010 |
Why?
|
| Computer Simulation | 1 | 2015 | 6195 | 0.010 |
Why?
|
| Seasons | 1 | 2008 | 1523 | 0.010 |
Why?
|
| Gene Expression Profiling | 1 | 2017 | 9374 | 0.010 |
Why?
|
| Urban Population | 1 | 2008 | 2015 | 0.010 |
Why?
|
| Reproducibility of Results | 1 | 2017 | 20031 | 0.010 |
Why?
|
| Case-Control Studies | 1 | 2017 | 21988 | 0.010 |
Why?
|
| Prospective Studies | 2 | 2017 | 54204 | 0.010 |
Why?
|
| Infant, Newborn | 2 | 2009 | 26109 | 0.010 |
Why?
|
| Molecular Sequence Data | 1 | 2010 | 17629 | 0.010 |
Why?
|
| Transcription Factors | 1 | 2017 | 12106 | 0.010 |
Why?
|
| Cell Line | 1 | 2010 | 15636 | 0.010 |
Why?
|
| Prevalence | 1 | 2012 | 15641 | 0.010 |
Why?
|
| Retrospective Studies | 2 | 2009 | 80121 | 0.010 |
Why?
|
| Mutation | 1 | 2012 | 29877 | 0.000 |
Why?
|
| Time Factors | 1 | 2009 | 40109 | 0.000 |
Why?
|
| Risk Factors | 1 | 2008 | 74167 | 0.000 |
Why?
|